Holen Sie sich die Stockscreener-App
23.43
2.29%
-0.55
Schlusskurs vom Vortag:
$23.98
Offen:
$23.87
24-Stunden-Volumen:
1.27M
Relative Volume:
1.44
Marktkapitalisierung:
$2.88B
Einnahmen:
$1.80B
Nettoeinkommen (Verlust:
$15.62M
KGV:
195.25
EPS:
0.12
Netto-Cashflow:
$118.36M
1W Leistung:
-3.58%
1M Leistung:
-2.42%
6M Leistung:
+0.47%
1J Leistung:
+3.99%
1-Tages-Spanne:
$23.17
$24.14
1-Wochen-Bereich:
$23.17
$26.51
52-Wochen-Spanne:
$18.77
$26.51
Privia Health Group Inc Stock (PRVA) Company Profile
Firmenname
Privia Health Group Inc
Sektor
Branche
Telefon
571-366-8850
Adresse
950 N. GLEBE RD., SUITE 700, ARLINGTON
Vergleichen Sie PRVA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRVA
Privia Health Group Inc
|
23.43 | 2.94B | 1.80B | 15.62M | 118.36M | 0.12 |
|
VEEV
Veeva Systems Inc
|
294.86 | 47.73B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
71.56 | 12.83B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
93.71 | 7.99B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
54.29 | 11.72B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
36.22 | 6.85B | 906.14M | -52.62M | 89.62M | -0.3621 |
Privia Health Group Inc Stock (PRVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-10 | Eingeleitet | Needham | Buy |
| 2024-12-16 | Eingeleitet | Macquarie | Outperform |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-04-22 | Eingeleitet | Citigroup | Buy |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-02-26 | Fortgesetzt | Jefferies | Buy |
| 2024-02-22 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-12-06 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-06-13 | Eingeleitet | Evercore ISI | Outperform |
| 2023-04-12 | Eingeleitet | Stephens | Overweight |
| 2023-03-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-02-03 | Eingeleitet | Goldman | Buy |
| 2022-12-09 | Eingeleitet | Stifel | Buy |
| 2022-12-08 | Eingeleitet | UBS | Buy |
| 2022-09-07 | Fortgesetzt | Truist | Buy |
| 2022-05-03 | Eingeleitet | BofA Securities | Buy |
| 2022-04-28 | Eingeleitet | BTIG Research | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-30 | Eingeleitet | Guggenheim | Buy |
| 2022-02-22 | Hochstufung | Cowen | Market Perform → Outperform |
| 2022-01-03 | Eingeleitet | Jefferies | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-05-24 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-05-24 | Eingeleitet | Credit Suisse | Outperform |
| 2021-05-24 | Eingeleitet | JP Morgan | Overweight |
| 2021-05-24 | Eingeleitet | Piper Sandler | Overweight |
| 2021-05-24 | Eingeleitet | Truist | Buy |
| 2021-05-24 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Privia Health Group Inc Aktie (PRVA) Neueste Nachrichten
How institutional buying supports Privia Health Group Inc. stock2025 Fundamental Recap & Consistent Profit Alerts - newser.com
Privia Health’s Earnings Call Highlights Robust Growth - The Globe and Mail
Privia Health Group, Inc. Hits New 52-Week High of $26.51 - Markets Mojo
Privia Health raises 2025 outlook with 32% adjusted EBITDA growth target amid value-based care expansion - MSN
Tick level data insight on Privia Health Group Inc. volatilityJuly 2025 Outlook & Stepwise Trade Signal Implementation - newser.com
Did Raised Guidance and Revenue Growth Just Shift Privia Health Group’s (PRVA) Investment Narrative? - Yahoo Finance
Multi asset correlation models including Privia Health Group Inc.M&A Rumor & Fast Entry Momentum Alerts - newser.com
How Privia Health Group Inc. (PRVA) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Privia Health Group, Inc. (NASDAQ:PRVA) Q3 2025 Earnings Call Transcript - Insider Monkey
Evercore ISI Group Raises Price Target for PRVA to $30.00 | PRVA Stock News - GuruFocus
Analyst Citizens Raises Price Target for Privia Health (PRVA) to $31 | PRVA Stock News - GuruFocus
Privia Health Group Inc (PRVA) Q3 2025 Earnings Call Highlights: Robust Growth and Strategic ... By GuruFocus - Investing.com Canada
Privia Health Q3 2025 Earnings: Revenue Beat, Raised 2025 Guidance | NASDAQ:PRVANews and Statistics - IndexBox
Privia Health: Q3 Earnings Snapshot - CT Insider
Why Privia Health Group Inc. stock remains on buy listsJuly 2025 Decliners & AI Optimized Trading Strategy Guides - newser.com
Privia Health Q3 2025 presentation: Revenue soars 27%, EBITDA jumps 62% as guidance raised - Investing.com Nigeria
PRVA Q3 Deep Dive: Acquisition and Value-Based Care Expansion Shape Outlook - Yahoo Finance
Privia Health Reports Strong Q3 2025 Results - The Globe and Mail
Decoding Privia Health Group Inc (PRVA): A Strategic SWOT Insigh - GuruFocus
Here's What Key Metrics Tell Us About Privia Health (PRVA) Q3 Earnings - sharewise.com
Privia Health stock price target raised to $30 from $28 at Evercore ISI - Investing.com Canada
Privia Health Group stock hits 52-week high at $26.50 By Investing.com - Investing.com South Africa
Privia Health Group, Inc. 2025 Q3ResultsEarnings Call Presentation (NASDAQ:PRVA) 2025-11-06 - Seeking Alpha
Privia Health Group, Inc. Updates Earrings Guidance for Full-Year 2025 - MarketScreener
Transcript : Privia Health Group, Inc., Q3 2025 Earnings Call, Nov 06, 2025 - MarketScreener
Privia Health Group stock hits 52-week high at $26.50 - Investing.com
Earnings call transcript: Privia Health Q3 2025 revenue beats forecast By Investing.com - Investing.com Nigeria
Earnings call transcript: Privia Health Q3 2025 revenue beats forecast - Investing.com India
Privia Health Raises Outlook Despite Revenue Miss In Q3 - Finimize
Privia Health Group, Inc. SEC 10-Q Report - TradingView
[10-Q] Privia Health Group, Inc. Quarterly Earnings Report | PRVA SEC FilingForm 10-Q - Stock Titan
Privia Health Group earnings missed, revenue topped estimates By Investing.com - Investing.com Canada
Privia Health Q3 Non-GAAP Earnings, Revenue Rise; Raises 2025 Revenue Guidance - MarketScreener
Can Privia Health Group Inc. stock maintain operating marginsMarket Activity Report & Safe Capital Allocation Plans - newser.com
Privia Health (PRVA) Lags Q3 Earnings Estimates - sharewise.com
(PRVA) Privia Health Group Expects Full Year 2025 Revenue Range $2.05B$2.10B, vs. FactSet Est of $2.00B - MarketScreener
Earnings Flash (PRVA) Privia Health Group, Inc. Reports Q3 Revenue $580.4M, vs. FactSet Est of $492.7M - MarketScreener
Earnings Flash (PRVA) Privia Health Group, Inc. Posts Q3 Adjusted EPS $0.29 per Share - MarketScreener
Privia Health (NASDAQ:PRVA) Surprises With Strong Q3 - Yahoo Finance
Privia Health Q3 revenue up 32.5%, raises FY forecast - MarketScreener
Privia Health Reports Third Quarter 2025 Financial Results - TradingView
[8-K] Privia Health Group, Inc. Reports Material Event | PRVA SEC FilingForm 8-K - Stock Titan
How to manage a losing position in Privia Health Group Inc.2025 Analyst Calls & Growth Focused Entry Reports - newser.com
Published on: 2025-11-06 05:39:24 - fcp.pa.gov.br
Understanding Privia Health Group Inc.’s price movementEarnings Summary Report & High Accuracy Trade Signal Alerts - newser.com
Will Privia Health Group Inc. stock remain a Wall Street favoriteJuly 2025 Volume & Safe Capital Growth Stock Tips - fcp.pa.gov.br
How Privia Health Group Inc. stock benefits from global expansionPortfolio Gains Summary & Reliable Intraday Trade Alerts - newser.com
Finanzdaten der Privia Health Group Inc-Aktie (PRVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.60%
0.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):